AUS
NZ
UK
CA
USA
IND
Healthcare
Zepp Health’s (NYSE:ZEPP) Q3 Revenue Hits USD 75.8M Amid New Product Launches
November 05, 2025 03:35 AM PST| By Team Kalkine MediaHighlights,Revenue rises 78.5% YoY to USD 75.8M, meeting upper end of guidance.,GAAP operating loss narrows to USD 0.9M and adjusted operating income reaches breakeven.,Cash and cash equivalents increase to USD 102.6M, up from USD 95.3M in Q2 2025.,Z...
Centene (NYSE:CNC) S&P 500 Fund Drives Managed Care Rise
November 03, 2025 12:00 AM PST| By Anmol KhazanchiCentene Corporation (NYSE:CNC) advances accessible healthcare through Medicaid and community programs, reflecting operational consistency and sector stability within the S&P 500 fund.
Merck (NYSE:MRK) S&P 500 Chart Mirrors Biotech Expansion
November 03, 2025 12:00 AM PST| By Team Kalkine MediaMerck & Co., Inc. (NYSE:MRK) strengthens its healthcare innovation through global research and diverse operations, reflecting scientific leadership and resilience shown across the S&P 500 Chart.
Stevanato Group (NYSE:STVN) Innovates Global Healthcare Design
November 03, 2025 12:00 AM PST| By Anmol KhazanchiStevanato Group S.p.A. (NYSE:STVN) enhances global healthcare through innovative packaging, containment, and automation systems, supporting the biopharma industry with precision and advanced engineering.
Cigna Group (NYSE:CI) Strengthens Integrated Care Model
October 31, 2025 12:00 AM PDT| By Anmol KhazanchiCigna Group (NYSE:CI) delivers global healthcare solutions through advanced technology, coordinated care, and wellness-focused services, reinforcing its leadership in medical, pharmaceutical, and behavioral health.
S&P Futures Strength Rise With Humana (NYSE:HUM) Operations
October 31, 2025 12:00 AM PDT| By Anmol KhazanchiHumana Inc. (NYSE:HUM) supports S&P futures through its integrated healthcare network, financial discipline, and technology-driven service framework, reflecting consistent stability in the U.S. health sector.
s&p 500 Trends Rise With Cardinal Health (NYSE:CAH) Expansion
October 31, 2025 12:00 AM PDT| By Anmol KhazanchiCardinal Health (NYSE:CAH) supports the S&P 500 through global healthcare distribution, advanced logistics, and sustainability initiatives that enhance operational efficiency and resilience across medical networks.
PTC Therapeutics (NASDAQ:PTCT) NASDAQ Composite Leads Biotech
October 31, 2025 12:00 AM PDT| By Anmol KhazanchiPTC Therapeutics (NASDAQ:PTCT) drives rare disease research and global biopharma innovation, aligning with technological and healthcare trends defining the Nasdaq Composite’s focus on scientific advancement.
S&P 500 Index Tracks Pfizer Inc. (NYSE:PFE) Health Leadership
October 30, 2025 12:00 AM PDT| By Anmol KhazanchiPfizer Inc. (NYSE:PFE) reinforces its leadership through vaccine innovation, global healthcare initiatives, and diversified therapeutics, mirroring the resilience and growth of major firms in the S&P 500 Index.
UnitedHealth Group Drops Amid Dow Jones Industrial Average Shift
October 29, 2025 04:45 PM PDT| By Anmol KhazanchiUnitedHealth Group (NYSE:UNH) faces a market decline, impacting Healthcare Stocks and the dow jones industrial index. Trading patterns and operational activities highlight sector trends and index movements.
Prime Medicine Update Reveals Latest Trends in Healthcare Stocks
October 29, 2025 04:15 PM PDT| By Anmol KhazanchiPrime Medicine (NYSE:PRME) drives innovation in Healthcare Stocks with its gene editing technology, strong market presence, institutional engagement, and research initiatives, highlighting its impact on the biotechnology sector.
Edwards Lifesciences (NYSE:EW) Market Activity and S&P 500 Futures
October 29, 2025 03:24 PM PDT| By Anmol KhazanchiEdwards Lifesciences (NYSE:EW) advances structural heart disease solutions, maintains strong market activity, and drives trends in the S&P 500 index, supported by global presence, technological innovation, and institutional participation.
Artivion (NYSE:AORT) Climbs in NYSE Composite Index Activity
October 29, 2025 02:58 PM PDT| By Anmol KhazanchiArtivion (NYSE:AORT) strengthens its role in Healthcare Stocks, showcasing advanced medical devices, operational growth, and market relevance while contributing to trends in the nyse composite index.
Artivion (NYSE:AORT) Elevates Momentum In NYSE Composite Index
October 29, 2025 12:00 AM PDT| By Anmol KhazanchiArtivion (NYSE:AORT) NYSE Composite Index performance reflects its leadership in cardiovascular and surgical device manufacturing, driving innovation through precision engineering and consistent global healthcare advancement.
Bristol Myers Squibb (NYSE:BMY) Strengthens Biopharma Reach
October 29, 2025 12:00 AM PDT| By Anmol KhazanchiBristol Myers Squibb (NYSE:BMY) expands its global biopharmaceutical portfolio through innovation in oncology, immunology, and cardiovascular therapies, reinforcing leadership in research-driven medical advancement.
Johnson & Johnson Performance in the Dow Jones Industrial Average
October 28, 2025 09:03 AM PDT| By Anmol KhazanchiJohnson & Johnson (NYSE:JNJ) leads Healthcare Stocks, driving innovation in pharmaceuticals and MedTech while strengthening its role within the dow jones industrial index and influencing dow jones stocks globally.
HCA Healthcare (NYSE:HCA) Advances Network Modernization
October 28, 2025 12:00 AM PDT| By Anmol KhazanchiHCA Healthcare (NYSE:HCA) strengthens its nationwide presence through an extensive network of hospitals and medical facilities, emphasizing quality care, operational integration, and innovation in patient services.
Teva Pharmaceutical (NYSE:TEVA) Expands Global Pharmaceutical Impact
October 27, 2025 11:32 AM PDT| By Anmol KhazanchiTeva Pharmaceutical (NYSE:TEVA) strengthens its global presence in Healthcare Stocks, delivering innovative medicines, advanced therapies, and reliable healthcare solutions through extensive international operations and technological integration.
Fate Therapeutics (NASDAQ:FATE) Reports New Data on FT819 CAR T-Cell Therapy
October 27, 2025 01:48 AM PDT| By Team Kalkine MediaHighlights,FT819 delivers sustained clinical improvements in treatment-refractory Systemic Lupus Erythematosus (SLE) patients.,Favorable safety profile with no dose-limiting toxicities or neurotoxicity observed.,Company in discussions with FDA under...
Encompass Health (NYSE:EHC) NYSE COMPOSITE TODAY Lifts Healthcare
October 27, 2025 12:00 AM PDT| By Anmol KhazanchiEncompass Health (NYSE:EHC) in the NYSE Composite Today advances post-acute rehabilitation, digital healthcare efficiency, and patient-centered recovery, reinforcing its leadership in U.S. medical service innovation.
